Does the media prefer PRVA or TEM?

In the previous week, Tempus AI had 37 more articles in the media than Privia Health Group. MarketBeat recorded 43 mentions for Tempus AI and 6 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.23 beat Tempus AI's score of 0.48 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tempus AI 22 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, HNGE or PRVA?

Privia Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hinge Health $587.86M 12.14 -$528.26M $1.28 69.09 Privia Health Group $2.12B 1.27 $22.92M $0.21 100.57

Does the media favor HNGE or PRVA?

In the previous week, Hinge Health had 4 more articles in the media than Privia Health Group. MarketBeat recorded 10 mentions for Hinge Health and 6 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.23 beat Hinge Health's score of 0.93 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, PRVA or CHE?

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Privia Health Group $2.12B 1.27 $22.92M $0.21 100.57 Chemed $2.53B 2.80 $265.24M $19.91 27.19

Does the media prefer PRVA or CHE?

In the previous week, Privia Health Group had 2 more articles in the media than Chemed. MarketBeat recorded 6 mentions for Privia Health Group and 4 mentions for Chemed. Chemed's average media sentiment score of 1.58 beat Privia Health Group's score of 1.23 indicating that Chemed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer PRVA or HIMS?

In the previous week, Hims & Hers Health had 35 more articles in the media than Privia Health Group. MarketBeat recorded 41 mentions for Hims & Hers Health and 6 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.23 beat Hims & Hers Health's score of 0.22 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 12 Very Positive mention(s) 4 Positive mention(s) 15 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RDNT or PRVA?

In the previous week, Privia Health Group had 1 more articles in the media than RadNet. MarketBeat recorded 6 mentions for Privia Health Group and 5 mentions for RadNet. RadNet's average media sentiment score of 1.67 beat Privia Health Group's score of 1.23 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Privia Health Group 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Privia Health Group (PRVA) Competitors

$21.12 -0.08 (-0.38%)

As of 08/21/2026 04:00 PM Eastern

Compare

PRVA vs. TEM, HNGE, CHE, HIMS, and RDNT

Should you buy Privia Health Group stock or one of its competitors? Privia Health Group's main competitors and comparable companies include Tempus AI (TEM), Hinge Health (HNGE), Chemed (CHE), Hims & Hers Health (HIMS), and RadNet (RDNT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Privia Health Group compare to Tempus AI?

Privia Health Group (NASDAQ:PRVA) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.

Privia Health Group has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Tempus AI has a beta of 3.58, suggesting that its stock price is 258% more volatile than the broader market.

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 24.2% of Tempus AI shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 24.3% of Tempus AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Privia Health Group currently has a consensus target price of $31.00, indicating a potential upside of 46.78%. Tempus AI has a consensus target price of $65.69, indicating a potential downside of 9.63%. Given Privia Health Group's stronger consensus rating and higher probable upside, research analysts clearly believe Privia Health Group is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41

In the previous week, Tempus AI had 37 more articles in the media than Privia Health Group. MarketBeat recorded 43 mentions for Tempus AI and 6 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.23 beat Tempus AI's score of 0.48 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tempus AI	22 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Privia Health Group has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.27	$22.92M	$0.21	100.57
Tempus AI	$1.27B	10.31	-$245.03M	-$1.44	N/A

Privia Health Group has a net margin of 1.19% compared to Tempus AI's net margin of -17.77%. Privia Health Group's return on equity of 3.52% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Tempus AI	-17.77%	-50.28%	-10.33%

Summary

Privia Health Group beats Tempus AI on 12 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Hinge Health presently has a consensus target price of $100.57, indicating a potential upside of 13.72%. Privia Health Group has a consensus target price of $31.00, indicating a potential upside of 46.78%. Given Privia Health Group's higher possible upside, analysts clearly believe Privia Health Group is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Privia Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	12.14	-$528.26M	$1.28	69.09
Privia Health Group	$2.12B	1.27	$22.92M	$0.21	100.57

Hinge Health has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market.

In the previous week, Hinge Health had 4 more articles in the media than Privia Health Group. MarketBeat recorded 10 mentions for Hinge Health and 6 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.23 beat Hinge Health's score of 0.93 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

94.5% of Privia Health Group shares are held by institutional investors. 18.9% of Hinge Health shares are held by company insiders. Comparatively, 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Hinge Health has a net margin of 15.15% compared to Privia Health Group's net margin of 1.19%. Hinge Health's return on equity of 51.60% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Privia Health Group	1.19%	3.52%	2.00%

Summary

Hinge Health beats Privia Health Group on 11 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Chemed?

Privia Health Group (NASDAQ:PRVA) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

Chemed has a net margin of 10.60% compared to Privia Health Group's net margin of 1.19%. Chemed's return on equity of 31.77% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Chemed	10.60%	31.77%	18.90%

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Privia Health Group has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market.

Privia Health Group currently has a consensus price target of $31.00, suggesting a potential upside of 46.78%. Chemed has a consensus price target of $530.75, suggesting a potential downside of 1.95%. Given Privia Health Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Privia Health Group is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.27	$22.92M	$0.21	100.57
Chemed	$2.53B	2.80	$265.24M	$19.91	27.19

In the previous week, Privia Health Group had 2 more articles in the media than Chemed. MarketBeat recorded 6 mentions for Privia Health Group and 4 mentions for Chemed. Chemed's average media sentiment score of 1.58 beat Privia Health Group's score of 1.23 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Chemed beats Privia Health Group on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Hims & Hers Health?

Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

In the previous week, Hims & Hers Health had 35 more articles in the media than Privia Health Group. MarketBeat recorded 41 mentions for Hims & Hers Health and 6 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.23 beat Hims & Hers Health's score of 0.22 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	12 Very Positive mention(s)	4 Positive mention(s)	15 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral

Privia Health Group currently has a consensus price target of $31.00, suggesting a potential upside of 46.78%. Hims & Hers Health has a consensus price target of $32.17, suggesting a potential downside of 4.46%. Given Privia Health Group's stronger consensus rating and higher possible upside, research analysts clearly believe Privia Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.27	$22.92M	$0.21	100.57
Hims & Hers Health	$2.35B	3.35	$128.37M	-$0.63	N/A

Privia Health Group has a net margin of 1.19% compared to Hims & Hers Health's net margin of -5.51%. Privia Health Group's return on equity of 3.52% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Privia Health Group has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, indicating that its share price is 140% more volatile than the broader market.

Summary

Privia Health Group beats Hims & Hers Health on 10 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to RadNet?

RadNet (NASDAQ:RDNT) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

77.9% of RadNet shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Privia Health Group has a net margin of 1.19% compared to RadNet's net margin of -0.93%. Privia Health Group's return on equity of 3.52% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Privia Health Group	1.19%	3.52%	2.00%

Privia Health Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.96	-$18.65M	-$0.27	N/A
Privia Health Group	$2.12B	1.27	$22.92M	$0.21	100.57

In the previous week, Privia Health Group had 1 more articles in the media than RadNet. MarketBeat recorded 6 mentions for Privia Health Group and 5 mentions for RadNet. RadNet's average media sentiment score of 1.67 beat Privia Health Group's score of 1.23 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Privia Health Group	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

RadNet currently has a consensus target price of $88.00, suggesting a potential upside of 14.55%. Privia Health Group has a consensus target price of $31.00, suggesting a potential upside of 46.78%. Given Privia Health Group's higher possible upside, analysts clearly believe Privia Health Group is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Summary

Privia Health Group beats RadNet on 12 of the 17 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRVA vs. The Competition

Export

Metric	Privia Health Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.70B	$9.83B	$7.38B	$12.85B
Dividend Yield	N/A	2.55%	2.53%	10.78%
P/E Ratio	100.58	29.19	211.08	20.91
Price / Sales	1.27	5.00	623.29	95.85
Price / Cash	79.14	125.12	78.62	53.99
Price / Book	3.22	4.05	13.05	6.20
Net Income	$22.92M	$311.06M	$3.47B	$348.59M
7 Day Performance	-4.00%	0.83%	2.09%	0.08%
1 Month Performance	-16.75%	1.29%	6.11%	2.91%
1 Year Performance	-3.96%	15.68%	25.00%	17.19%

Privia Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRVA Privia Health Group	4.5424 of 5 stars	$21.12 -0.4%	$31.00 +46.8%	-1.0%	$2.70B	$2.12B	100.58	1,226	Positive News
TEM Tempus AI	1.571 of 5 stars	$49.59 -4.0%	$64.92 +30.9%	-5.2%	$8.94B	$1.27B	N/A	3,800	Trending News Analyst Forecast Insider Trade Options Volume
HNGE Hinge Health	3.7454 of 5 stars	$88.82 +1.1%	$100.57 +13.2%	+57.8%	$7.17B	$720.06M	69.47	1,437	Insider Trade
CHE Chemed	4.062 of 5 stars	$532.72 +1.5%	$530.75 -0.4%	+19.1%	$6.96B	$2.53B	26.76	15,811
HIMS Hims & Hers Health	1.8605 of 5 stars	$27.85 -2.7%	$32.43 +16.5%	-23.1%	$6.50B	$2.58B	N/A	2,442	Trending News Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRVA) was last updated on 8/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Privia Health Group (PRVA) Competitors

PRVA vs. TEM, HNGE, CHE, HIMS, and RDNT

How does Privia Health Group compare to Tempus AI?

Summary

How does Privia Health Group compare to Hinge Health?

Summary

How does Privia Health Group compare to Chemed?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Summary

How does Privia Health Group compare to RadNet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Privia Health Group (PRVA) Competitors

PRVA vs. TEM, HNGE, CHE, HIMS, and RDNT

How does Privia Health Group compare to Tempus AI?

Which has more volatility & risk, PRVA or TEM?

Do institutionals and insiders have more ownership in PRVA or TEM?

Do analysts rate PRVA or TEM?

Does the media prefer PRVA or TEM?

Which has preferable earnings & valuation, PRVA or TEM?

Is PRVA or TEM more profitable?

Summary

How does Privia Health Group compare to Hinge Health?

Do analysts recommend HNGE or PRVA?

Which has preferable earnings and valuation, HNGE or PRVA?

Which has more risk and volatility, HNGE or PRVA?

Does the media favor HNGE or PRVA?

Do institutionals & insiders believe in HNGE or PRVA?

Is HNGE or PRVA more profitable?

Summary

How does Privia Health Group compare to Chemed?

Is PRVA or CHE more profitable?

Do insiders and institutionals hold more shares of PRVA or CHE?

Which has more volatility & risk, PRVA or CHE?

Do analysts recommend PRVA or CHE?

Which has preferable earnings & valuation, PRVA or CHE?

Does the media prefer PRVA or CHE?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Does the media prefer PRVA or HIMS?

Do analysts prefer PRVA or HIMS?

Which has better earnings and valuation, PRVA or HIMS?

Is PRVA or HIMS more profitable?

Do institutionals and insiders hold more shares of PRVA or HIMS?

Which has more volatility and risk, PRVA or HIMS?

Summary

How does Privia Health Group compare to RadNet?

Do insiders and institutionals have more ownership in RDNT or PRVA?

Is RDNT or PRVA more profitable?

Which has higher valuation and earnings, RDNT or PRVA?

Does the media refer more to RDNT or PRVA?

Which has more risk and volatility, RDNT or PRVA?

Do analysts recommend RDNT or PRVA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools